Suchergebnisse - "Khoundabi, Batoul"

PubPharm (39)

21

Oxygenation Efforts for Iranian COVID-19 ARDS Patients : First 5-Day Crisis Experience Scenario

enthalten in: Tanaffos | 2020

von Hashemian, S. | Khoundabi, B. | Tabarsi, P.

22

Sleep Disorders and Mental Health in Menopausal Women in Tehran

enthalten in: Tanaffos | 2020

von Adimi Naghan, P. | Hassani, S. | Sadr, M. | +5

23

Nutritional status of patients hospitalized in the intensive care unit : A comprehensive report from Iranian hospitals, 2018

enthalten in: Journal of critical care | 2019

von Javid Mishamandani, Z. | Norouzy, A. | Hashemian, S. | +13

24

The effect of acetazolamide on the improvement of central apnea caused by abusing opioid drugs in the clinical trial

enthalten in: Sleep and breathing | 2019

von Naghan, P. | Raeisi, K. | Khoundabi, B. | +5

25

The effect of acetazolamide on the improvement of central apnea caused by abusing opioid drugs in the clinical trial

enthalten in: Sleep and breathing | 2019

von Naghan, P. | Raeisi, K. | Khoundabi, B. | +5

26

The effect of acetazolamide on the improvement of central apnea caused by abusing opioid drugs in the clinical trial

enthalten in: Sleep and breathing | 2019

von Naghan, P. | Raeisi, K. | Khoundabi, B. | +5

27

Correction to : Exhaled nitric oxide is not a biomarker for idiopathic pulmonary arterial hypertension or for treatment efficacy

enthalten in: BMC pulmonary medicine | 2019

von Malekmohammad, M. | Folkerts, G. | Kashani, B. | +6

ErratumFor: BMC Pulm Med. 2019 Oct 29;19(1):188. - PMID 31664957

28

Correction to: Exhaled nitric oxide is not a biomarker for idiopathic pulmonary arterial hypertension or for treatment efficacy

enthalten in: BMC pulmonary medicine | 2019

von Malekmohammad, M. | Folkerts, G. | Kashani, B. | +6

29

Correction to: Exhaled nitric oxide is not a biomarker for idiopathic pulmonary arterial hypertension or for treatment efficacy

enthalten in: BMC pulmonary medicine | 2019

von Malekmohammad, M. | Folkerts, G. | Kashani, B. | +6

30

Exhaled nitric oxide is not a biomarker for idiopathic pulmonary arterial hypertension or for treatment efficacy

enthalten in: BMC pulmonary medicine | 2019

von Malekmohammad, M. | Folkerts, G. | Kashani, B. | +6

ErratumIn: BMC Pulm Med. 2019 Nov 5;19(1):197. - PMID 31690288